MRC Epidemiology Unit

 

Plasma N-terminal Prosomatostatin and Risk of Incident Cardiovascular Disease and All-Cause Mortality in a Prospective Observational Cohort: the PREVEND Study.

Abbasi A, Kieneker LM, Corpeleijn E, Gansevoort RT, Gans RO, Struck J, de Boer RA, Hillege HL, Stolk RP, Navis G, and Bakker SJ

Clinical chemistry. May 2016

(DOI : 10.1373/clinchem.2016.259275)

---

Bilirubin as a potential causal factor in type 2 diabetes risk: a Mendelian randomization study.

Abbasi A, Deetman PE, Corpeleijn E, Gansevoort RT, Gans RO, Hillege HL, van der Harst P, Stolk RP, Navis G, Alizadeh BZ, and Bakker SJ

Diabetes. Nov 2014

(DOI : 10.2337/db14-0228)

---

Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.

Abbasi A, Corpeleijn E, Gansevoort RT, Gans RO, Struck J, Schulte J, Hillege HL, van der Harst P, Stolk RP, Navis G, and Bakker SJ

Diabetologia. Feb 2014

(DOI : 10.1007/s00125-014-3278-9)

---